Medtronic plc (MDT)
NYSE: MDT · IEX Real-Time Price · USD
79.47
+0.28 (0.35%)
Apr 19, 2024, 10:53 AM EDT - Market open

Medtronic Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Year 2023202220212020201920182017201620152014 2013 - 1995
Net Income
3,7585,0393,6064,7894,6313,1044,0283,5382,6753,065
Upgrade
Depreciation & Amortization
2,6972,7072,7022,6632,6592,6442,9172,8201,306850
Upgrade
Share-Based Compensation
355359344297290344348375439145
Upgrade
Other Operating Activities
-771-759-412-515-573-1,408-413-1,515482899
Upgrade
Operating Cash Flow
6,0397,3466,2407,2347,0074,6846,8805,2184,9024,959
Upgrade
Operating Cash Flow Growth
-17.79%17.72%-13.74%3.24%49.59%-31.92%31.85%6.45%-1.15%0.34%
Upgrade
Capital Expenditures
-1,459-1,368-1,355-1,213-1,134-1,068-1,254-1,046-571-396
Upgrade
Acquisitions
-1,867-91-994-488-1,8275,921-1,324-1,213-14,884-385
Upgrade
Change in Investments
-171-190-463-1,4652,1511,0279854,518-1,692-2,784
Upgrade
Other Investing Activities
4-10-54-3736-2222-1489-29
Upgrade
Investing Cash Flow
-3,493-1,659-2,866-3,203-7745,858-1,5712,245-17,058-3,594
Upgrade
Dividends Paid
-3,616-3,383-3,120-2,894-2,693-2,494-2,376-2,139-1,337-1,116
Upgrade
Share Issuance / Repurchase
-337-2,115-178-664-1,885-1,768-3,116-2,339-1,271-1,246
Upgrade
Debt Issued / Paid
-598-1-570-559-867-7,5982,183-5,12518,6731,431
Upgrade
Other Financing Activities
-409163-268-8114-942660-11613
Upgrade
Financing Cash Flow
-4,960-5,336-4,136-4,198-5,431-11,954-3,283-9,54315,949-918
Upgrade
Exchange Rate Effect
243-231215-86-7811465113-35337
Upgrade
Net Cash Flow
-2,171121-547-253724-1,2982,091-1,9673,440484
Upgrade
Free Cash Flow
4,5805,9784,8856,0215,8733,6165,6264,1724,3314,563
Upgrade
Free Cash Flow Growth
-23.39%22.37%-18.87%2.52%62.42%-35.73%34.85%-3.67%-5.08%1.74%
Upgrade
Free Cash Flow Margin
14.67%18.87%16.22%20.82%19.22%12.07%18.94%14.47%21.38%26.83%
Upgrade
Free Cash Flow Per Share
3.444.453.634.494.362.674.082.963.954.55
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).